Prevention of bleomycin-induced pulmonary fibrosis by a RANKL peptide in mice

Despite the recent therapeutic developments for the treatment of pulmonary fibrosis, its prognosis is still not well controlled, and a novel therapeutic agent is needed. Recently, the critical role of Toll-like receptors (TLRs) in the pathophysiology of pulmonary fibrosis has been reported; however,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ju, Nan, Hayashi, Hiroki, Shimamura, Munehisa, Baba, Satoshi, Yoshida, Shota, Morishita, Ryuichi, Rakugi, Hiromi, Nakagami, Hironori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304352/
https://www.ncbi.nlm.nih.gov/pubmed/35864207
http://dx.doi.org/10.1038/s41598-022-16843-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304352/
https://www.ncbi.nlm.nih.gov/pubmed/35864207
http://dx.doi.org/10.1038/s41598-022-16843-7

Ejemplares similares